Milestone Scientific (NYSE:MLSS) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report report published on Tuesday morning. The brokerage issued a hold rating on the stock.

Separately, Benchmark reiterated a “speculative buy” rating and issued a $1.25 price target on shares of Milestone Scientific in a research report on Wednesday, November 20th.

Milestone Scientific Trading Up 6.6 %

Shares of NYSE MLSS opened at $1.30 on Tuesday. The firm has a market cap of $101.26 million, a PE ratio of -18.57 and a beta of 1.10. Milestone Scientific has a 1-year low of $0.54 and a 1-year high of $1.32. The company has a fifty day moving average price of $0.93 and a 200 day moving average price of $0.92.

Institutional Trading of Milestone Scientific

A number of hedge funds have recently bought and sold shares of the business. Carnegie Investment Counsel increased its position in Milestone Scientific by 18.9% in the fourth quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock worth $166,000 after buying an additional 27,412 shares during the last quarter. World Investment Advisors LLC purchased a new stake in Milestone Scientific in the 3rd quarter worth about $91,000. Geode Capital Management LLC increased its holdings in Milestone Scientific by 6.4% in the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after acquiring an additional 31,572 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd bought a new stake in Milestone Scientific in the 3rd quarter valued at about $48,000. 5.79% of the stock is currently owned by institutional investors.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.